Monthly Archives: May, 2013
Guest Post : IBS- A Canadian Perspective, Tapping into Key Resources
Blogger Lyndin Kane of Running From the Runs returns this week with a post for her fellow Canadians with IBS, which was written especially for IBS Impact. Readers from all over the world, also see her popular guest post from April 8, 2013 for IBS Awareness Month, which was reposted from her own blog with …
Representative Davis of California Co-Sponsors HR 842 for Functional Gastrointestinal and Motility Disorders
UPDATE: 06/13/2015: HR 842 did not pass, but a similar bill, HR 2311, is currently in the House of Representatives for 2015-2016. Please click on the HR 2311 sub-category on the right sidebar of this blog to see the relevant posts. According to THOMAS, the Library of Congress legislative database, and IFFGD/the Digestive Health Alliance, as …
Restroom Access Act (Ally’s Law) Updates in Maryland and Maine
As of last month, April 2013, there are positive updates to report in two more U.S. states regarding Restroom Access Acts, popularly known as Ally’s Law. This brings the number of states with known restroom access laws, allowing people with medical conditions to use employee-only restrooms in retail establishments, to fifteen. In Maryland, according to …
Representative Kind of Wisconsin Co-Sponsors HR 842 for Functional Gastrointestinal and Motility Disorders
UPDATE: 06/13/2015: HR 842 did not pass, but a similar bill, HR 2311, is currently in the House of Representatives for 2015-2016. Please click on the HR 2311 sub-category on the right sidebar of this blog to see the relevant posts. According to THOMAS, the Library of Congress legislative database, and IFFGD/the Digestive Health Alliance, as …
Food and Drug Administration Selects IBS, GERD and Gastroparesis for Patient-Focused Initiative
Last week, the International Foundation for Functional Gastrointestinal Disorders and its grassroots arm, the Digestive Health Alliance, announced that the U.S. Food and Drug Administration has chosen three functional gastrointestinal and motility disorders to be included in its “patient focused initiative.” (See IFFGD/DHA April 2013 FDA news here.) The FDA is responsible for the review, …
IBS IMPACT 